Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. DocMorris AG's Average Total Inventories for the quarter that ended in Jun. 2025 was CHF40 Mil. DocMorris AG's Revenue for the
six
months ended in Jun. 2025 was CHF541 Mil.
DocMorris AG's Inventory-to-Revenue for the quarter that ended in Jun. 2025 was 0.07.
DocMorris AG's Inventory-to-Revenue for the quarter that ended in Jun. 2025
declined
from Dec. 2024 (0.08) to Dec. 2024 (0.07)
A decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
DocMorris AG's Days Inventory for the
six
months ended in Jun. 2025 was 17.45.
Inventory Turnover measures how fast the company turns over its inventory within a year.
DocMorris AG's Inventory Turnover for the quarter that ended in Jun. 2025 was 10.46.
DocMorris AG (XSWX:DOCM) Inventory-to-Revenue Explanation
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
DocMorris AG's Days Inventory for the
six
months ended in Jun. 2025 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG Inventory-to-Revenue Related Terms
DocMorris AG Inventory-to-Revenue Historical Data
* Premium members only.
The historical data trend for DocMorris AG's Inventory-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG Inventory-to-Revenue Competitor Comparison
For the Pharmaceutical Retailers subindustry, DocMorris AG's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DocMorris AG Inventory-to-Revenue vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, DocMorris AG's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where DocMorris AG's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
DocMorris AG's Inventory-to-Revenue for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DocMorris AG (XSWX:DOCM) has a Inventory-to-Revenue of 0.07 as of Jun. 2025. Inventory-to-Sales ratio is the total inventories divided by total sales. View historical data on DocMorris AG and its competitors.
Is DocMorris AG's Inventory-to-Revenue too high?
DocMorris AG's current Inventory-to-Revenue is 0.07. Overall, DocMorris AG has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does DocMorris AG's Inventory-to-Revenue compare to competitors?
DocMorris AG's Inventory-to-Revenue of 0.07 can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventory-to-Revenue for a Healthcare Providers & Services company?
A good Inventory-to-Revenue depends on the Healthcare Providers & Services industry context. However, Inventory-to-Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventory-to-Revenue mean?
A high Inventory-to-Revenue can signal that a stock is expensive relative to its fundamentals. Inventory-to-Sales ratio is the total inventories divided by total sales. View historical data on DocMorris AG and its competitors. DocMorris AG's current Inventory-to-Revenue is 0.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DocMorris AG stock overvalued right now?
Based on GuruFocus' analysis, DocMorris AG (XSWX:DOCM) is currently considered Fairly Valued. The stock's GF Value™ is CHF10.69, compared to a current price of CHF10.36 — trading 3.1% below its estimated fair value. The current Inventory-to-Revenue is 0.07. DocMorris AG's overall GF Score™ is 65/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventory-to-Revenue calculated?
Inventory-to-Revenue is calculated from a company's financial statements. For DocMorris AG (XSWX:DOCM), the current Inventory-to-Revenue is 0.07 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DocMorris AG (XSWX:DOCM) Overvalued in 2026?
Based on GuruFocus' analysis, DocMorris AG stock appears to be undervalued.
The current stock price of CHF10.36 is trading 3.1% below its estimated GF Value™ of CHF10.69.
GuruFocus considers DocMorris AG to be Fairly Valued.
Key valuation signals for XSWX:DOCM:
Inventory-to-Revenue: 0.07
GF Value™: CHF10.69 vs. price of CHF10.36 (3.1% below fair value)
No single metric tells the full story. See the XSWX:DOCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DocMorris AG is engaged in the fields of online pharmacy, marketplace, and professional healthcare with brands in Germany and other European countries. Its brands are DocMorris, PromoFarma by DocMorris, and TeleClinic. The Group's reportable segments are Germany and Europe. The Germany segment comprises the mail-order business in drugs and health products, as well as services for mail-order pharmacies. The Europe segment comprises the marketplace business of PromoFarma and Doctipharma. The majority of revenue is generated from Germany segment.
65GF Score
Get the complete analysis for XSWX:DOCM
Inventory-to-Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:DOCM has been successfully added to your 
